CD8A and lymphopenia: Previous studies on SARS-CoV-1 [53], as well as a number of recent studies on SARS-CoV-2 [27, 29, 54–56], indicate the development of lymphopenia with a sharply reduced number of both CD4 and CD8 T cells in moderate and severe clinical forms.